Total Payments
$287,757
2024 Payments
$35,244
Companies
27
Transactions
321
Medicare Patients
505
Medicare Billing
$90,427
Payment Breakdown by Category
Other$220,521 (76.6%)
Travel$31,295 (10.9%)
Consulting$28,003 (9.7%)
Food & Beverage$7,817 (2.7%)
Education$120.54 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $220,521 | 65 | 76.6% |
| Travel and Lodging | $31,295 | 74 | 10.9% |
| Consulting Fee | $28,003 | 9 | 9.7% |
| Food and Beverage | $7,817 | 170 | 2.7% |
| Education | $120.54 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $150,375 | 158 | $0 (2019) |
| GlaxoSmithKline, LLC. | $91,482 | 47 | $0 (2024) |
| ABBVIE INC. | $21,683 | 15 | $0 (2024) |
| Clovis Oncology, Inc. | $17,893 | 28 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $3,577 | 9 | $0 (2020) |
| Medical Device Business Services, Inc. | $1,250 | 7 | $0 (2024) |
| Amgen Inc. | $323.73 | 14 | $0 (2020) |
| PFIZER INC. | $257.79 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $150.03 | 9 | $0 (2019) |
| EISAI INC. | $129.58 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,244 | 30 | ABBVIE INC. ($21,646) |
| 2023 | $7,725 | 6 | GlaxoSmithKline, LLC. ($7,625) |
| 2022 | $55,790 | 23 | GlaxoSmithKline, LLC. ($55,580) |
| 2021 | $12,934 | 11 | GlaxoSmithKline, LLC. ($12,934) |
| 2020 | $7,763 | 15 | Clovis Oncology, Inc. ($4,353) |
| 2019 | $43,360 | 81 | TESARO, Inc. ($26,090) |
| 2018 | $79,544 | 99 | TESARO, Inc. ($79,082) |
| 2017 | $45,396 | 56 | TESARO, Inc. ($45,204) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $128.98 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: OB/GYN | ||||||
| 11/15/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,257.00 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $48.63 | General |
| 10/04/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $35.75 | General |
| 10/04/2024 | Ethicon US, LLC | Echelon Circular (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Endo-Mechanical | ||||||
| 10/04/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $13.34 | General |
| 10/03/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $575.67 | General |
| 10/03/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $212.53 | General |
| 10/03/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $202.27 | General |
| 10/03/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $161.42 | General |
| 10/03/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Wound Closure | ||||||
| 10/03/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Wound Closure | ||||||
| 10/02/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $108.12 | General |
| Category: Oncology | ||||||
| 09/25/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $1,113.65 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,457.00 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | Cash or cash equivalent | $283.99 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | Cash or cash equivalent | $229.68 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,257.00 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $69.62 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Oncology | ||||||
| 03/20/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $120.71 | General |
| Category: Oncology | ||||||
| 03/13/2024 | ABBVIE INC. | ELAHERE (Drug) | Consulting Fee | Cash or cash equivalent | $8,278.00 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $352.20 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 119 | 165 | $59,509 | $25,026 |
| 2022 | 5 | 91 | 97 | $55,877 | $22,230 |
| 2021 | 4 | 58 | 59 | $38,451 | $13,366 |
| 2020 | 6 | 237 | 292 | $144,847 | $29,805 |
Total Patients
505
Total Services
613
Medicare Billing
$90,427
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 14 | 14 | $24,256 | $10,347 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 53 | $13,703 | $5,469 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $12,260 | $5,342 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $5,674 | $2,167 | 38.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 26 | $3,616 | $1,701 | 47.1% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 16 | 16 | $32,016 | $12,973 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $9,623 | $3,663 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 30 | $7,759 | $3,297 | 42.5% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 11 | 11 | $4,110 | $1,359 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $2,369 | $938.35 | 39.6% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 11 | 11 | $25,058 | $8,118 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $7,077 | $2,476 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $3,716 | $1,578 | 42.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $2,600 | $1,194 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 136 | $50,168 | $11,599 | 23.1% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 15 | 15 | $47,774 | $7,826 | 16.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 47 | 47 | $26,367 | $6,105 | 23.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 59 | $14,875 | $2,976 | 20.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $5,180 | $1,237 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 19 | 21 | $483.00 | $61.76 | 12.8% |
About Dr. John Mcbroom, MD
Dr. John Mcbroom, MD is a Gynecologic Oncology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568439768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mcbroom, MD has received a total of $287,757 in payments from pharmaceutical and medical device companies, with $35,244 received in 2024. These payments were reported across 321 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($220,521).
As a Medicare-enrolled provider, Mcbroom has provided services to 505 Medicare beneficiaries, totaling 613 services with total Medicare billing of $90,427. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Gynecologic Oncology
- Location Naples, FL
- Active Since 03/07/2006
- Last Updated 07/10/2025
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1568439768
Products in Payments
- ZEJULA (Drug) $237,147
- ELAHERE (Drug) $21,646
- Rubraca (Drug) $17,850
- LYNPARZA (Drug) $3,577
- JEMPERLI (Biological) $2,400
- TIVDAK (Biological) $257.79
- Neulasta (Biological) $217.62
- Lenvima (Drug) $129.58
- MVASI (Biological) $106.11
- Avastin (Biological) $101.00
- KEYTRUDA (Biological) $98.40
- myRisk (Device) $97.45
- SANCUSO (Drug) $49.14
- VARUBI (Drug) $47.61
- STRATAFIX (Device) $44.81
- Da Vinci Surgical System (Device) $36.38
- Orilissa (Drug) $36.20
- OVA1 (Device) $23.69
- Mobile Laser Services (Medical Supply) $23.37
- YONDELIS (Drug) $22.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.